| Patents for C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671) |
|---|
| 11/25/2004 | WO2003101405A3 Aminoglycoside antibiotics and methods of using same |
| 11/25/2004 | US20040236085 Solid-phase nucleophilic fluorination |
| 11/25/2004 | US20040234634 Pharmaceutical compositions having appetite suppressant activity |
| 11/24/2004 | CN1548445A N-crotonoyl hydroxy protected glucosamine and its prepn and application |
| 11/18/2004 | US20040230047 Coupling phosphoramidites; phosphates removable in one deprotection step; solid phase synthesis |
| 11/18/2004 | US20040230046 Lincomycin derivatives possessing antibacterial activity |
| 11/18/2004 | US20040229265 Amino-modified polysaccharides and methods of generating and using same |
| 11/18/2004 | US20040228935 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 11/17/2004 | EP1476454A1 Binding epitopes for helicobacter pylori and use thereof |
| 11/17/2004 | CN1176094C Synthesis of trichlorosucrose |
| 11/11/2004 | WO2004096821A1 Improved crystalline form of sucralose, and method for producing it |
| 11/10/2004 | EP0970096B1 Chromatographic purification of chlorinated sucrose |
| 11/04/2004 | WO2004093867A2 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
| 11/04/2004 | WO2004093787A2 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 11/04/2004 | WO2004060347A3 Pharmaceutical propylene glycol solvate compositions |
| 11/04/2004 | US20040220398 continuously crystallizing sucralose from an aqueous solution by continuous removal and recirculation of the vessel contents, and providing a long residence time for sucralose in the system |
| 11/03/2004 | EP1471870A2 Use of lipid conjugates in the treatment of disease |
| 11/03/2004 | CN1543471A Process for producing sugar chain asparagine derivative |
| 11/02/2004 | US6812223 Crystalline glucosamine sulfate metal salts and processes for preparing the same |
| 10/28/2004 | US20040215004 One step process for the preparation of anticonvulsant derivatives |
| 10/27/2004 | EP1471052A1 Geranyl compounds |
| 10/26/2004 | US6809198 Sucralose composition and process for its preparation |
| 10/21/2004 | US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 10/14/2004 | US20040204370 such as N-deacetyl-N-(4-fluorophenoxyacetyl)thiocolchicine; liposomes; antitumor agents; anticancer agents |
| 10/13/2004 | EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid |
| 10/07/2004 | WO2004084912A1 Remedy for nerve damage |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/06/2004 | EP1291349B1 Malto-oligosaccharide derivatives and use thereof |
| 10/06/2004 | CN1534039A Production method of 2-deoxy-N-phenyl pentosamine |
| 09/30/2004 | US20040192907 Comprises dried carrageenan derivatives for use as viscosity enhancing agents in foods; gelling agents |
| 09/30/2004 | US20040192618 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
| 09/29/2004 | EP1461045A2 Glucosamine organic acid adducts |
| 09/23/2004 | WO2004080409A2 Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus |
| 09/23/2004 | WO2004041199A3 N-acetyl-d-glucosamine (nag) supplemented food products and beverages |
| 09/23/2004 | US20040185538 by converting alkyl 2-deoxy-2-halo-R- alpha / beta -D-gluco/mannopyranoside by reduction to alkyl 2-deoxy- alpha / beta -D-glucopyranoside and hydrolysis |
| 09/22/2004 | EP1458732A1 Method for preparing a glucosamine compound, and compound thus obtained |
| 09/21/2004 | US6794497 Aminofuranose compounds |
| 09/21/2004 | US6794372 Nitrate salts of antimicrobial agents |
| 09/16/2004 | WO2004078769A1 Process for the preparation of anticonvulsant derivatives of topiramate |
| 09/16/2004 | US20040181054 Process for producing sugar chain asparagine derivative |
| 09/16/2004 | US20040180852 Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus |
| 09/16/2004 | CA2517964A1 Process for the preparation of anticonvulsant derivatives of topiramate |
| 09/15/2004 | EP1455800A1 Process for the preparation of glucosamine salts |
| 09/15/2004 | EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 09/15/2004 | CN1528770A Method for preparing-trichloro sucrose-6-ethyl ester |
| 09/10/2004 | WO2004075843A2 Glycosolated enkephalin agents |
| 09/10/2004 | CA2507527A1 Glycosolated enkephalin agents |
| 09/09/2004 | US20040176317 Functionalised maltosyl fluoride as glycosyl donor in the chemo-enzymatic preparation of ratio of oligo-or polysaccharides |
| 09/09/2004 | US20040176281 Pharmaceutical carriers comprised of at least mono- or oligosaccharide and lipidic moiety; intestinal absorption |
| 09/02/2004 | WO2004045371A3 Methods for diagnosing the presence or stage of cancer |
| 09/02/2004 | US20040170735 Methods and compositions for altering the sweetness delivery profile of sucralose |
| 09/01/2004 | CN1164604C Acetamido lactose PEG glycoside and dimer with activity of resisting tumor metastasis |
| 08/26/2004 | WO2004032826A3 Process for preparing tannate tablet capsule or other solid dosage forms |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/25/2004 | CN1163236C Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/19/2004 | US20040161475 Anticancer, antitumor agents; ssynergistic mixtures with retinoic acid; olid tumors |
| 08/18/2004 | EP1228079B1 Novel fucosylated oligosaccharides and process for their preparation |
| 08/18/2004 | CN1521176A Method for producing highly pure acarbose |
| 08/12/2004 | WO2004066915A2 Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof |
| 08/12/2004 | WO2004045545A3 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 08/12/2004 | US20040157247 Of given formula; used to build up oligomers which can be used for hybridization, probes and detection of nucleic acids; protecting groups, fluorescent dyes, solid phase, phosphoramidite, phosphonate or triphosphate |
| 08/11/2004 | CN1520315A Solid-phase nucleophilic fluorination |
| 08/11/2004 | CN1161367C Prepn of aminoglucose hydrochloride |
| 08/10/2004 | CA2130124C Anomeric fluororibosyl amines |
| 08/05/2004 | WO2004065401A1 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 08/05/2004 | WO2004065399A1 N-glycoside type glycolipids and hollow fiber type organic nanotubes made of the same |
| 08/05/2004 | WO2004064754A2 Bioadhesive pharmaceutical compositions |
| 08/05/2004 | WO2003073988A3 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof |
| 08/05/2004 | WO2003047501A3 Novel anti-cancer therapeutic compounds |
| 08/05/2004 | US20040149200 Crystals of an oligosaccharides and process for preparation thereof |
| 08/05/2004 | CA2513304A1 Bioadhesive pharmaceutical compositions |
| 08/04/2004 | CN1517803A Dephotoresist agent |
| 08/04/2004 | CN1160081C Combination therapy of HIV infection using HIV protease inhibitior induinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 08/03/2004 | US6770635 Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions |
| 08/03/2004 | US6770259 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 07/29/2004 | WO2004063209A2 Methods of producing c-aryl glucoside sglt2 inhibitors |
| 07/29/2004 | WO2004062599A2 Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 07/29/2004 | US20040147730 Inhibitors against galectins |
| 07/29/2004 | CA2512389A1 Methods of producing c-aryl glucoside sglt2 inhibitors |
| 07/29/2004 | CA2512108A1 Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 07/28/2004 | EP1003760B1 Prodrugs and conjugates of selenium containing compounds and use thereof |
| 07/28/2004 | CN1159329C Glucoamino derivative and its preparing process |
| 07/28/2004 | CN1159328C Water soluble chitosamine, use thereof and prepn. method therefor |
| 07/22/2004 | WO2004060347A2 Pharmaceutical propylene glycol solvate compositions |
| 07/22/2004 | US20040142880 delivery of topically active therapeutic agents such as mesalamine to the duodenal, jejunal or proximal small bowel |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/21/2004 | EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite |
| 07/21/2004 | CN1513849A Mannitol and sorbierite derivative |
| 07/21/2004 | CN1158294C Process for preparing trichlorosucrose-6-ester |
| 07/15/2004 | WO2004058786A1 Process for the synthesis of 2-deoxy-d-glucose |
| 07/15/2004 | US20040138439 Methods of producing C-aryl glucoside SGLT2 inhibitors |
| 07/15/2004 | US20040138425 Site-specific aminoglycoside derivatives for use in immunodiagnostic assays |
| 07/15/2004 | US20040137379 Photoresist stripping agent |
| 07/14/2004 | EP1437139A2 Method for protection against genotoxic mutagenesis |
| 07/14/2004 | EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/07/2004 | CN1156483C Method for preparing organic azide |
| 07/06/2004 | US6759406 Quaternary ammonium compounds |